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Abstract (250 words) 25 
Porcine reproductive and respiratory syndrome virus (PRRSV) plays a key role in 26 
porcine respiratory disease complex modulating the host immune response and favouring 27 
secondary bacterial infections. Pulmonary alveolar macrophages (PAMs) are the main 28 
cells supporting PRRSV replication, with CD163 as the essential receptor for viral 29 
infection. Although interstitial pneumonia is by far the representative lung lesion, 30 
suppurative bronchopneumonia is described for PRRSV virulent strains. This research 31 
explores the role of several immune markers potentially involved in the regulation of the 32 
inflammatory response and sensitisation of lung to secondary bacterial infections by 33 
PRRSV-1 strains of different virulence. Conventional pigs were intranasally inoculated 34 
with the virulent subtype 3 Lena strain or the low virulent subtype 1 3249 strain and 35 
euthanised at 1, 3, 6 and 8 dpi. Lena-infected pigs exhibited more severe clinical signs, 36 
macroscopic lung score and viraemia associated with an increase of IL-6 and IFN-γ in 37 
sera compared to 3249-infected pigs. Extensive areas of lung consolidation corresponding 38 
with suppurative bronchopneumonia were observed in Lena-infected pigs. Lung viral 39 
load and PRRSV-N-protein+ cells were always higher in Lena-infected animals. PRRSV-40 
N-protein+ cells were linked to a marked drop of CD163+ macrophages. The number of 41 
CD14+ and iNOS+ cells gradually increased along PRRSV-1 infection, being more 42 
evident in Lena-infected pigs. The frequency of CD200R1+ and FoxP3+ cells peaked late 43 
in both PRRSV-1 strains, with a strong correlation between CD200R1+ cells and lung 44 
injury in Lena-infected pigs. These results highlight the role of molecules involved in the 45 
earlier and higher extent of lung lesions in piglets infected with the virulent Lena strain, 46 
pointing out the activation of routes potentially involved in the restraint of the local 47 
inflammatory response.  48 
 49 




Porcine reproductive and respiratory syndrome virus (PRRSV) encompasses two 52 
species, Betaarterivirus suid 1 and Betaarterivirus suid 2 (formerly, PRRSV-1 and 53 
PRRSV-2, respectively) (Gorbalenya et al., 2018), which present a wide inter- and intra-54 
species viral diversity (Balka et al., 2018; Shi et al., 2010; Stadejek et al., 2013). Since 55 
2006, different outbreaks characterised by high morbidity and mortality rates, fever, 56 
haemorrhages, severe lesions in lung and, eventually, in other organs such as thymus or 57 
lymph nodes, have been reported associated with virulent PRRSV-1 strains (Canelli et 58 
al., 2017; Karniychuk et al., 2010; Morgan et al., 2013, 2016; Ogno et al., 2019; Sinn et 59 
al., 2016; Weesendorp et al., 2013). Several contradictory results about viraemia, tissue 60 
viral load, early virus clearance, low frequencies of PRRSV-specific IFN-γ secreting cells 61 
or PRRSV neutralizing antibodies have been reported after infection with PRRSV-1 62 
virulent strains. However, there is consensus on the fact that some strains are more 63 
virulent than others (Canelli et al., 2017; Ferrari et al., 2018; Frydas et al., 2013; Geldhof 64 
et al., 2012; Morgan et al., 2013; Renson et al., 2017; Stadejek et al., 2017; Weesendorp 65 
et al., 2013, 2014).  66 
 67 
PRRSV replicates predominantly in the lung , causing a mild to severe interstitial 68 
pneumonia which may be complicated to suppurative bronchopneumonia due to the 69 
increased lung sensitisation to bacterial infections associated with the damage and 70 
impairment of the different pulmonary macrophage subpopulations (pulmonary alveolar 71 
macrophages, PAMs; pulmonary intravascular macrophage, PIMs; and interstitial 72 
macrophages) (Brockmeier et al., 2017; Thanawongnuwech et al., 2000). PAMs are the 73 
main cellular target of PRRSV, although  interstitial and intravascular macrophages can 74 
be infected too (Bordet et al., 2018; Duan et al., 1997; Gómez-Laguna et al., 2010), with 75 
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the nucleocapsid protein N (PRRSV-N-protein) as the most abundant viral protein during 76 
PRRSV infection (Rowland et al., 1999). PAMs express high levels of CD163 scavenger 77 
receptor (Sánchez et al., 1999; Van Gorp et al., 2008) which is essential to support 78 
PRRSV internalisation and disassembly interacting with GP2 and GP4 viral proteins 79 
(Burkard et al., 2017; Das et al., 2010; Whitworth et al., 2016). A soluble form of CD163 80 
(sCD163), that may be released from tissue macrophages and monocytes, has been 81 
identified in plasma as potential biomarker for macrophage activity and inflammation 82 
(Costa-Hurtado et al., 2013; Møller, 2012; Pasternak et al., 2019).  83 
 84 
PRRSV is known to modulate the host immune response by inducing changes in the 85 
frequencies of immune cell subsets in blood (Dwivedi et al., 2012; Ferrari et al., 2018; 86 
Morgan et al., 2013; Weesendorp et al., 2013) and in tissues (Gómez-Laguna et al., 2010; 87 
Rodríguez-Gómez et al., 2013), leading to an enhanced susceptibility to secondary 88 
bacterial infections (Karniychuk et al., 2010; Renson et al., 2017; Sinn et al., 2016). An 89 
early decrease in the frequency of monocytes, NK cells or cytotoxic T cells linked to a 90 
strong inflammatory response in target organs has been described upon experimental 91 
infection with PRRSV-1 virulent strains (Ferrari et al., 2018; Morgan et al., 2013; 92 
Weesendorp et al., 2013; 2014). In addition, some studies indicate an early 93 
overproduction of pro-inflammatory cytokines, such as IFN-γ, IL-1β or IL-8, as the main 94 
source of pulmonary injury after infection with virulent PRRSV-1 strains (Amarilla et al., 95 
2015; Morgan et al., 2013; Renson et al., 2017; Weesendorp et al., 2014). Nevertheless, 96 
other potential mechanisms, such as an imbalance among pro- and anti-inflammatory 97 
responses, might predispose to secondary infections contributing to the onset of the 98 
porcine respiratory disease complex (PRDC) (Gómez-Laguna et al., 2013; Van Gucht et 99 




In this context, overproduction of nitric oxide (NO), mainly triggered by inducible NO 102 
synthase (iNOS) (Akaike and Maeda, 2000), or upregulation of CD14, as the primary 103 
lipopolysaccharide (LPS) receptor (Zanoni and Granucci, 2013), could contribute to lung 104 
inflammation upon infection with PRRSV (Chen et al., 2014; Lee and Kleiboeker, 2005; 105 
Van Gucht et al., 2004, 2005; Yan et al., 2017). By contrast, the transcription factor 106 
forkhead box protein 3 (FoxP3), is an essential transcription factor for the development 107 
of regulatory T cells (Tregs) and hence, a useful marker to detect them. This subset could 108 
be involved in supressing the activation of other T-cell populations (Käser et al., 2008). 109 
CD200 receptor 1 (CD200R1), expressed on myeloid cells and B cell subsets (Poderoso 110 
et al., 2019), is an inhibitory surface receptor that might deliver inhibitory signals 111 
dampening the activation of cells which express it (Vaine and Soberman, 2014). Thus, 112 
both immune markers might play an important role inhibiting the production of pro-113 
inflammatory cytokines (Elmore et al., 2014; Nedumpun et al., 2018; Singh et al., 2019; 114 
Vaine and Soberman, 2014; Wang et al., 2018), lessening the exuberant lung injury 115 
observed with virulent PRRSV-1 strains. Whereas all these markers may play a key role 116 
in PRRSV virulence, there are scarce studies analysing their role in the context of the 117 
lung lesion. Therefore, the systemic immune response and immunopathology of lung are 118 
evaluated in this study with the goal of exploring the role of selected immune markers in 119 
the pro- and anti-inflammatory priming of the lung to secondary bacteria after infection 120 
with a virulent PRRSV-1 strain (subtype 3, Lena strain) in comparison with a low virulent 121 
PRRSV-1 strain (subtype 1, 3249 strain).   122 
 123 
2. Materials and methods 124 
2.1. Porcine reproductive and respiratory syndrome strains 125 
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The low virulent 3249 strain (subtype 1 PRRSV-1) was isolated from the serum of a piglet 126 
with pneumonia from a PRRSV-positive herd located in Spain in 2005 (Gimeno et al., 127 
2011). The virulent Lena strain (subtype 3 PRRSV-1) is considered as the prototype of 128 
PRRSV-1 virulent strains. Lena strain isolation was performed from lung homogenates 129 
obtained from weak born piglets from a PRRSV-positive herd from Belarus in 2007 with 130 
a high mortality rate, reproductive failure and respiratory disorders (Karniychuk et al., 131 
2010). Viral stocks were produced from the 4th passage of each strain on PAMs, titrated 132 
by means of immunoperoxidase monolayer assay and expressed as tissue culture 133 
infectious doses 50 (TCID50)/mL (3249 strain: 10
5.79 TCID50/mL; Lena strain: 10
5.66 134 
TCID50/mL).  135 
 136 
2.2. Animals and experimental design  137 
The animals and samples used in this study were part of a project to investigate the 138 
pathogenesis of the infection with PRRSV-1 strains of different virulence (Rodríguez-139 
Gómez et al., 2019). Briefly, fifty-two 4-week-old male and female piglets (Landrace x 140 
Large White crossbred) were obtained from a historically PRRSV-negative farm. All pigs 141 
were negative for porcine circovirus type 2 (PCV2), PRRSV and Mycoplasma 142 
hyopneumoniae by ELISA and PCR assays (Mattsson et al., 1995; Sibila et al., 2004).  143 
 144 
Piglets were blocked by weight and sex and randomly assigned to three different groups 145 
and housed in separate pens: Lena group (n=20), 3249 group (n=20) and control group 146 
(n=12). After an acclimation period of seven days, piglets were intranasally inoculated 147 
with either the low virulent 3249 strain or the virulent Lena strain (both used at 148 
1x105 TCID50/mL, 1 mL/nostril, using the MAD Nasal™ Intranasal Mucosal Atomization 149 
Device, Teleflex, Alcalá de Henares, Madrid, Spain). The control group was mock-150 
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inoculated with the PAM supernatant diluted with RPMI similarly to the inoculum. Three 151 
control pigs and five infected pigs from each group were euthanised on days 1, 3, 6 and 152 
8 post-inoculation (dpi). This experiment was conducted according to the guidelines of 153 
the European Union (Directive 2010/63/EU) and approved by the IRTA Ethics 154 
Committee and by the Catalan Autonomous Government (Project 3647; FUE-2017-155 
00533413). 156 
 157 
2.3. Clinical signs, gross pathology and histopathology of lung  158 
Commencing 1 day prior to inoculation, piglets were daily monitored to evaluate clinical 159 
signs (liveliness, respiratory symptoms and anorexia) and rectal temperature.  160 
Quantification of clinical signs was performed by applying the following clinical score: 161 
liveliness (score 0, no abnormalities; score 1, reduced liveliness but with response to 162 
external stimuli; score 2, pig prostration; score 3, agonic pig); respiratory symptoms 163 
(score 0, no abnormalities; score 1, mild dyspnoea; score 2, evident dyspnoea; score 3, 164 
evident dyspnoea with tachypnoea; score 4, evident dyspnoea, tachypnoea and cyanosis); 165 
and anorexia (score 0, eating without abnormality; score 1, sporadic frequency of eating;  166 
score 2, no eating). The sum of these scores represented the total clinical score per animal 167 
and per day. Rectal temperatures > 40.5 °C were considered hyperthermia. At 168 
necropsy, gross lung lesions were recorded and scored by the same pathologist (Halbur 169 
et al., 1996).  Afterwards, samples from apical, medial and caudal lobes from the right 170 
lung were collected and fixed in 10 % neutral-buffered formalin (Fisher Scientific Ltd., 171 
Loughborough, UK) for histopathological and immunohistochemical studies.  172 
 173 
Four-micron tissue sections were stained with haematoxylin and eosin and blindly graded 174 
by two pathologists for the histopathological evaluation. The severity of histopathological 175 
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lesions in the lung was scored as previously described by Halbur et al. (1996): 0, no 176 
microscopic lesions; 1, mild interstitial pneumonia; 2, moderate multifocal interstitial 177 
pneumonia; 3, moderate diffuse interstitial pneumonia; and 4, severe interstitial 178 
pneumonia. In addition, a similar score was developed considering the diagnosis of 179 
suppurative bronchopneumonia (Rodríguez-Gómez et al., 2019): 0, no microscopic 180 
lesions; 1, mild bronchopneumonia; 2, moderate multifocal bronchopneumonia; 3, 181 
moderate diffuse bronchopneumonia; and 4, severe bronchopneumonia. Altogether, the 182 
final score included the total of both, the interstitial pneumonia score and the 183 
bronchopneumonia score, being 8 points the maximum possible score. 184 
 185 
2.4. Viral genome quantification  186 
RNA was isolated from sera using NucleoSpin® RNA virus (Macherey-Nagel, Düren, 187 
Germany) according to manufacturer’s instructions. For lung, RNA was purified from 188 
tissue homogenate using a combined procedure with TRIzol™ (Thermo Fisher Scientific, 189 
Barcelona, Spain) and NucleoSpin® RNA Virus columns (Macherey-Nagel) according to 190 
manufacturer’s instructions. Viral load for either 3249 strain or Lena strain was quantified 191 
by RT-qPCR using VetMAX™ PRRSV EU/NA 2.0 kit (Thermo Fisher Scientific, 192 
Barcelona, Spain). Amplifications were performed in duplicate from each animal in the 193 
QuantStudio 5 Real-time PCR System (Thermo Fisher Scientific) for 5 minutes (min) at 194 
50 °C, 10 min at 95 °C followed by 40 cycles of 3 seconds (s) at 95 °C and 30 s at 60 °C. 195 
PRRSV RNA quantification was performed using specific primers of the target gene 196 
(Lena strain ORF7: forward primer AGCGCCAATTCAGAAAGAAA, reverse primer 197 
TGGATCGATTGCAGACAGAG; 3249 strain ORF7: forward primer  198 
GGCAAACGAGCTGTTAAACG, reverse primer AATTTCGGTCACATGGTTCC; 199 
Darwich et al., 2011). The ORF7 RT-PCR product from both 3249 and Lena strains was 200 
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firstly EtOH precipitated and purified using ExoSAP-ITTM (Thermo Fisher Scientific, 201 
Barcelona, Spain). The purified products were quantified using BioDrop (BioDrop, UK). 202 
Serial 10-fold dilutions of 3249 or Lena ORF7 RT-PCR products with known quantities, 203 
ranging from 108 to 102 genomic copies/mL were used as standards to generate a standard 204 
curve and, therefore, to determine the PRRSV genomic copies in sera and lung. The RT-205 
qPCR efficiency (E) was estimated for each strain by a linear regression model. The E 206 
value was calculated from the slope of the standard curve according to equation: 207 
E=10(−1/slope) -1. Also, a set of eight serial 10-fold dilutions of know TCID50/mL (starting 208 
from 106 TCID50/mL) was included in order to determine a relation between Ct-values, 209 
genomic copies/mL and TCID50/mL. An inter-run calibrator sample with a known 210 
number of PRRSV copies was introduced in each experiment to self-control inter-run 211 
variation. The area under the curve (AUC) for viremia and lung viral load was calculated 212 
using the trapezoidal approach (Greenbaum et al., 2001). Results of viral load in sera and 213 
lung are showed in equivalent TCID 50 (eq TCID50) per mL.  214 
 215 
2.5. Antibody and serological assessments  216 
Specific antibodies against PRRSV were detected using IDEXX PRRS X3 ELISA test 217 
(IDEXX laboratories, Barcelona, Spain) following manufacturer’s instructions. Levels of 218 
IFN-γ, IL-6 and IL-10 and the acute phase protein lipopolysaccharide binding protein 219 
(LBP) as well as the soluble form of swine CD163 (sCD163) were assessed in sera from 220 
all piglets. Different commercially available ELISA tests were used in accordance with 221 
manufacturer’s guidelines (IFN-γ, IL-6, IL-10 [Invitrogen, Barcelona, Spain]; LBP, 222 
[Hycult Biotech, Uden, Netherlands]; sCD163 [Cusabio Biotech, Houston, USA]). 223 
Results were expressed in pg/mL for IFN-γ, IL-6 and IL-10, and ng/mL for LBP and 224 
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sCD163. The minimum detectable concentrations were 2 pg/mL for IFN-γ, 45 pg/mL for 225 
IL-6, 3 pg/mL for IL-10, 1.6 ng/mL for LBP and 23.4 ng/mL for sCD163. 226 
 227 
2.6. Immunohistochemistry in lung tissue 228 
Four-micron sections from lung were dewaxed in xylene and rehydrated in descending 229 
grades of alcohol until distilled water. Then, endogenous peroxidase inhibition was 230 
performed in a 3% H2O2 solution in methanol for 30 min. Epitope demasking, primary 231 
antibodies dilutions and blocking of non-specific binding are detailed in Table 1. 232 
Monoclonal primary antibodies were incubated overnight at 4 ºC in a humid chamber. 233 
Polyclonal goat anti-mouse immunoglobulins (Agilent Technologies, Madrid, Spain) or 234 
polyclonal goat anti-rabbit immunoglobulins (Vector laboratories, USA) biotinylated 235 
secondary antibodies were accordingly incubated for 30 min at room temperature. After 236 
washing in PBS, Avidin–Biotin–Peroxidase complex technique (ABC Vector Elite, 237 
Vector laboratories, USA) was applied and the immunolabelling was revealed by 238 
application of NovaRED™ substrate kit (Vector Laboratories). Sections were 239 
counterstained with Harris’s haematoxylin, dehydrated and mounted. PBS (pH 7.4) and 240 
Tris buffered saline (pH 7.6) were used as wash and diluent buffers, respectively. 241 
Antibody specificity was verified by exchanging the primary antibody by isotype 242 
matched reagents of irrelevant specificity. One negative control which consisted of 243 
replacement of the primary antibody by BSA blocking solution was included in each 244 
immunohistochemical assay to rule out non-specific bindings.  245 
 246 
2.7. Immunohistochemistry cell counting 247 
The number of immunolabelled cells was quantified in 25 non-overlapping selected high 248 
magnification fields of 0.2 mm2 (Olympus BX51, Olympus Iberia SAU, L’Hospitalet de 249 
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Llobregat, Barcelona, Spain) and expressed as the mean of the score for each animal per 250 
mm2. Labelled cells were morphologically identified by differentiating among PAMs, 251 
PIMs and interstitial macrophages. 252 
 253 
2.8. Statistical analyses  254 
Differences between groups were evaluated for approximate normality of distribution by 255 
the D’Agostino and Pearson omnibus normality test followed by the Mann Whitney’s U 256 
non-parametric mean comparisons test. Correlation coefficients were assessed by the 257 
Spearman and Pearson tests and were considered relevant with r > 0.6 and P < 0.05. Data 258 
analyses and figures were performed by using GraphPad Prism 7.0 software (GraphPad 259 
Prism software 7.0, Inc., San Diego, CA, USA) and InkScape 0.92 software. A P value 260 
lower than 0.05 was considered statistically significant and represented as * P ≤ 0.05, ** 261 
P ≤ 0.01 *** P ≤ 0.001 and **** P ≤ 0.0001. 262 
 263 
3. Results 264 
3.1. Acute suppurative bronchopneumonia and the highest rectal temperature and 265 
clinical signs score were observed in Lena-infected pigs  266 
Clinical observations and gross pathology of lung were described thoroughly by 267 
Rodríguez-Gómez et al. (2019). In brief, piglets inoculated with virulent Lena strain had 268 
a long period of hyperthermia (mean rectal temperature above 40.5 °C) with marked 269 
clinical signs score from 4 dpi onwards, both peaking at 6 dpi (Figs. 1A-1B, clinical signs 270 
score and temperature). By contrast, an increase in rectal temperature below the 271 
hyperthermic threshold accompanied by mild clinical signs was observed in piglets 272 
infected with 3249 strain (Figs. 1A-1B). At necropsy, tan-mottled areas, atelectasis, 273 
rubbery consistency, and consolidated areas were observed in the lungs from both 274 
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PRRSV-1-infected pigs whose macroscopic lung score gradually increased throughout 275 
the study (Figs. 1C-1D). In particular, a stronger and earlier onset of the lung lesion (from 276 
6 dpi onwards) associated with the presence of extensive consolidated areas in apical and 277 
medial lobes as well as more severe interstitial pneumonia were observed in Lena-278 
infected pigs causing the highest macroscopic lung score compared to 3249-infected pigs 279 
(Figs. 1C-1D).  280 
 281 
A mild to moderate interstitial pneumonia with thickening of the alveolar septa by 282 
infiltrate of lymphocytes and macrophages was caused by both Lena and 3249 strains 283 
(Figs. 1E-1F). Furthermore, a suppurative bronchopneumonia characterised by 284 
neutrophils, cell debris and mucus filling the bronchial, bronchiolar and alveolar lumen 285 
was observed in lung section from Lena-infected pigs at 6 and 8 dpi (Figs. 1E-1F). A 286 
strong statistical correlation was found among temperature, clinical signs score, 287 
macroscopic and microscopic lung scores in Lena-infected pigs (Table 2). 288 
 289 
3.2. Viraemia and lung viral load followed a similar kinetics in PRRSV-1-infected pigs 290 
Viraemia and lung viral load were determined by RT-qPCR (efficiency of 99 %; slope = 291 
3.34; detection limit: 1 copy/µl; slope-intercept = 39.5; and high linearity, r = 0.99). All 292 
animals were negative by RT-qPCR at day 0 and control pigs remained so all throughout 293 
the experiment. In sera, four out of five 3249-infected pigs and all Lena-infected pigs 294 
were PRRSV positive as early as 1 dpi. Viraemia was always higher in Lena- than in 295 
3249-infected pigs from 1 to 8 dpi (P < 0.01 at 1, 3, 6 dpi; P<0.05 at 8 dpi), reaching the 296 
highest viral load at 6 dpi (1.9x107 eq TCID50/mL). The AUC for viremia (mean) in Lena 297 
and 3249 group were 44.8 and 33.8 respectively (Fig. 2A). The viral load in the lung 298 
displayed a similar kinetics to that of serum for both infected groups, reaching the 299 
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maximum lung viral loads at 6 dpi in Lena group (1.6x107 eq TCID50/mL), whereas 3249 300 
group peaked at 8 dpi (1.9x106 eq TCID50/mL) (Fig. 2B). By contrast to sera, PRRSV-1 301 
was just detected in lung in two out of five animals in both infected groups at 1 dpi, being 302 
positive all infected piglets from 3 dpi onwards. The AUC for lung viral load (mean) in 303 
Lena group was 45 and 36.2 for 3249 group (Fig. 2B). In Lena infected-group the 304 
statistical analysis revealed a positive correlation among viraemia, lung viral load, 305 
temperature, clinical signs score and the number of PRRSV-N-protein+ cells in the lungs 306 
(Table 2). A correlation among lung viral load and viraemia and PRRSV-N-protein+ cells 307 
was also observed in 3249-infected pigs (r = 0.71, P < 0.0001; and, r = 0.60, P < 0.005, 308 
respectively). 309 
 310 
3.3. A significant increase in the serum concentration of IFN-γ was observed in Lena-311 
infected pigs when compared with 3249-infected pigs  312 
PRRSV-specific antibodies were first detected at 8 dpi in sera from both PRRSV-1-313 
infected groups (non-significant differences in S/P ratios) (data not shown). A significant 314 
increase in IFN-γ serum levels was detected after Lena infection at 6 and 8 dpi (maximum 315 
mean level of 234 ± 100 pg/mL at 6 dpi) compared to control (P<0.05) and 3249 (P<0.01) 316 
groups (Fig. 2C). Maximum IL-6 levels in serum of 3249 group were observed at 6 dpi 317 
(mean of 350 ± 220 pg/mL), whereas pigs belonging to Lena group reached the highest 318 
IL-6 levels at 8 dpi (mean of 480 ± 50 pg/mL) (Fig. 2D). IL-10, LBP or sCD163 were not 319 
detected in serum samples from both control and infected groups throughout the study. 320 
Both viraemia and lung viral load displayed a positive statistical correlation with IFN-γ 321 
levels, which in turn were also correlated with temperature and the clinical signs score in 322 




3.4. The increase in the number of PRRSV-N-protein+ cells was associated with a 325 
decrease of CD163+ macrophages in the lung of PRRSV-infected pigs  326 
The labelling of PRRSV-N-protein was mainly observed in PAMs and in a lesser extent 327 
in interstitial and intravascular macrophages (Figs. 3A-3B). In Lena-infected pigs, 328 
clusters of PRRSV-N-protein+ macrophages were observed within foci of 329 
bronchopneumonia at 6 and 8 dpi (Fig. 3B inset). A progressive increase in the number 330 
of PRRSV-N-protein+ cells was detected throughout the study in both PRRSV-1-infected 331 
groups, reaching a peak at 6 and 8 dpi in Lena and 3249-infected piglets, respectively. 332 
This increase was significantly higher in Lena than in 3249 group (P<0.05 at 3, 6 and 8 333 
dpi) (Fig. 3E, primary axis). No positive cells were detected in control pigs. 334 
 335 
CD163 immunolabelling was detected in the cell membrane and cytoplasm of PAMs, 336 
interstitial macrophages and, occasionally, intravascular macrophages (Figs. 3C-3D, 337 
insets). A drop in the number of CD163+ cells was observed from 3 to 8 dpi in both 338 
PRRSV-1-infected groups. This decrease was more intense in Lena-infected animals 339 
when compared to 3249 (P<0.05 at 3 dpi) and control groups (P<0.05 at 3 and 8 dpi) (Fig. 340 
3E, secondary axis). By contrast, the frequency of CD163+ cells remained constant in 341 
control pigs during the whole study. Of note, PAMs were the subset of pulmonary 342 
macrophages which underwent the strongest reduction in the number of CD163+ cells. 343 
Furthermore, the frequency of CD163+ cells showed a strong negative correlation with 344 
lung viral load and the number of PRRSV-N-protein+ cells in Lena infected-pigs (Fig. 345 
3E) (Table 2).  346 
 347 
3.5. A strong influx of CD14+ macrophages and monocytes infiltrating the interstitium 348 
was detected in Lena-infected pigs 349 
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The labelling against CD14 was mainly observed in the cell membrane and cytoplasm of 350 
monocytes, interstitial and intravascular macrophages and, occasionally, in PAMs (Figs. 351 
4A-4B, insets). Whereas no changes were observed in the number of CD14+ cells in the 352 
control group along the study, a gradual increase with maximum expression at 8 dpi was 353 
detected in both infected groups (Fig. 4E). Lena-infected pigs showed the highest 354 
frequency of CD14+ cells when compared to control animals (P<0.01) in association with 355 
the presence of suppurative bronchopneumonia (Fig. 4B). CD14+ interstitial and 356 
intravascular macrophages were observed infiltrating extensive areas of the interstitium, 357 
whereas almost no CD14+ cells were present in the bronchial wall and alveolar lumen. 358 
Interestingly, the number of CD14+ cells in Lena-infected piglets displayed a strong 359 
positive correlation with the concentration of IL-6 in sera (Table 2). 360 
 361 
3.6. Lena virulent strain induced a strong increase of iNOS+ cells associated with a 362 
higher microscopic lung lesion 363 
The granular intracytoplasmic immunostaining of iNOS was primarily observed in PAMs 364 
and interstitial macrophages in foci of interstitial pneumonia and bronchopneumonia 365 
(Figs. 4C-4D). The number of iNOS+ cells followed a similar kinetics in both PRRSV-1-366 
infected groups, with a progressive increase from 6 dpi onwards, reaching a significant 367 
increase by the end of the study (8 dpi) in Lena-infected pigs compared to 3249 (P<0.01) 368 
and control groups (P<0.05) (Fig. 4F).  369 
  370 
3.7. The increase of CD200R1+ cells along the study was highly correlated with the 371 
course of lung injury  372 
CD200R1 labelling was detected in the cytoplasm of intravascular and interstitial 373 
macrophages located inside or surrounding bronchopneumonia foci, with occasional 374 
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expression in PAMs and monocytes (Figs. 5A-5B, insets). Whereas the number of 375 
CD200R1+ cells significantly increased in Lena-infected pigs at 6-8 dpi (P<0.05 at 6 dpi 376 
with respect to 3249 group; and P<0.01 at 6 dpi and P<0.05 at 8 dpi with respect to control 377 
group), this increase was just detected at 8 dpi in 3249-infected pigs (P<0.05 with respect 378 
to control group) (Fig. 5E, primary axis). Control animals presented a scarce number of 379 
CD200R1+ cells along the study. For Lena infected-pigs a strong positive correlation was 380 
observed among the frequency of CD200R1+ cells and the microscopic lung lesions (Fig. 381 
5E) (Table 2).  382 
 383 
 3.8. Both PRRSV-1 strains induced an increase of FoxP3+ cells at 6-8 dpi. 384 
FoxP3 yielded a nuclear immunolabelling in lymphocytes mainly located in areas of 385 
atelectasis and interstitial pneumonia (Figs. 5C-5D, insets). Although two Lena-infected 386 
pigs exhibited a higher number of FoxP3+ cells at 1 dpi, the kinetics of positive cells for 387 
this immune markers showed a gradual increase along the study in both Lena- and 3249-388 
infected animals, reaching the maximum at 6 dpi (Fig. 5F). There were no significant 389 
differences in the number of FoxpP3+ cells among infected groups. However, a significant 390 
increase of FoxP3+ cells was detected at 6 and 8 dpi in Lena-infected pigs compared to 391 
control animals (P<0.05).   392 
 393 
Discussion 394 
PRRSV plays a pivotal role in PRDC, modulating the host immune response and 395 
favouring secondary bacterial infections (Gómez-Laguna et al., 2013; Van Gucht et al., 396 
2004). Virulent PRRSV-1 strains cause more severe clinical signs, higher mortality rates 397 
as well as marked lung injury with a higher incidence of bronchopneumonia as opposed 398 
to low virulent strains (Amarilla et al., 2015; Canelli et al., 2017; Frydas et al., 2013; 399 
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Gómez-Laguna et al., 2010; Morgan et al., 2013; Renson et al., 2017; Rodríguez-Gómez 400 
et al., 2019; Stadejek et al., 2017; Weesendorp et al., 2013). Accordingly, we hypothesise 401 
that severe pulmonary lesions observed along infection with virulent PRRSV-1 strains 402 
might be associated with a higher decrease in the amount of PAMs as well as an 403 
imbalance between anti- and pro-inflammatory responses with different molecules 404 
potentially involved in this process.  405 
 406 
As previously described (Renson et al., 2017; Weesendorp et al., 2013), severe systemic 407 
and respiratory symptoms as well as hyperthermia were observed in animals infected with 408 
virulent Lena strain, whereas low virulent 3249 strain only caused mild clinical signs and 409 
a slightly increase of rectal temperature. Furthermore, virulent Lena strain caused an 410 
earlier and stronger onset of lung lesions due to extensive consolidated areas in the apical 411 
and medial lobes which were microscopically linked to suppurative bronchopneumonia 412 
as well as severe characteristic interstitial pneumonia. On the other hand, PRRSV 413 
virulence has been associated with higher virus titre and antibody response in vivo 414 
(Brockmeier et al., 2012; Lu et al., 2014) Although Lena virulent strain elicited a quite 415 
higher viraemia than the low virulent strain, no differences were observed in the antibody 416 
response in the early phase of infection. Similar results have been previously reported by 417 
others when comparing Lena with low virulent strains (Renson et al., 2017; Weesendorp 418 
et al., 2013), and confirm that PRRSV-1 virulence and specific non-neutralizing 419 
antibodies are not associated in the acute phase of infection. 420 
 421 
PRRSV infection with virulent strains usually induces a strong inflammatory immune 422 
response when compared with low virulent strains (Amarilla et al., 2015; Liu et al., 2010; 423 
Morgan et al., 2013; Renson et al., 2017; Weesendorp et al., 2013). In our study, higher 424 
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levels of IL-6 at 8 dpi and IFN-γ at 6-8 dpi were detected in the sera of Lena-infected 425 
pigs. Increased concentration of IL-6 in plasma is associated with both systemic and 426 
respiratory symptoms (Van Reeth and Nauwynck, 2000) and could play a dual role during 427 
virus infection: (i) protecting the host from infection and (ii) inducing inflammation and 428 
tissue damage when it is overexpressed (Liu et al., 2010). It is known that IFN-γ is, mostly 429 
produced by activated NK cells, NKT cells, γ/δ T cells, cytotoxic T cells and memory T 430 
cells (Gerner et al., 2015; Mair et al., 2014), and participates in regulating the immune 431 
and inflammatory responses (Van Reeth and Nauwynck, 2000). In fact, an early increase 432 
of NKT cells has been associated with viraemia peak in piglets infected with PR40 433 
virulent strain (Ferrari et al., 2018). In our study, virulent Lena strain elicited a marked 434 
increase in the serum level of IFN-γ which was significantly correlated with viremia and 435 
lung viral load, suggesting an attempt of the host innate immune response in controlling 436 
virus replication. The enhanced serum concentration of IL-6 could mirror the stronger 437 
systemic inflammatory response induced by Lena during the acute phase response 438 
contributing to the fever and more severe clinical signs as well as lung lesion that 439 
specifically arise in virulent PRRSV-1 strains (Amarilla et al., 2015; Renson et al., 2017).  440 
  441 
In order to evaluate the kinetics of PRRSV-1 in the lung, we analysed the expression of 442 
PRRSV-N-protein and lung viral load. Interestingly, both the number of PRRSV-N-443 
protein+ cells and lung viral load showed a solid negative correlation with the frequency 444 
of CD163+ cells, the essential host receptor for PRRSV infection (Burkard et al., 2017; 445 
Van Gorp et al., 2008; Whitworth et al., 2016). The dramatical depletion in the frequency 446 
of pulmonary CD163+ cells in Lena-infected animals has been already reported in live 447 
PAMs from the BALF of Lena-infected piglets (Renson et al., 2017; Rodríguez-Gómez 448 
et al., 2019) as well as from lung tissue sections of piglets infected with virulent SU1-bel 449 
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strain (Sánchez-Carvajal et al., 2019). This finding could be due to the direct cytopathic 450 
effect of the virus in its target cell but also to an indirect induction of regulated cell death 451 
in infected and non-infected cells, which has been broadly described in the lung and 452 
lymphoid organs of pigs infected with virulent PRRSV-1 strains (Morgan et al., 2013; 453 
Ruedas-Torres et al., 2020; Sánchez-Carvajal et al., 2019). Another possibility would be 454 
the shedding of sCD163 due to macrophages activation either by a direct effect of the 455 
virus or secondary to viral infection (Møller, 2012). However, it seems unlikely, since no 456 
changes were detected in sCD163 sera concentration in our study after infection with a 457 
virulent PRRSV-1 strain. In contrast, Glaesserella parasuis virulent strains have been 458 
reported to increase serum levels of sCD163 linked to a reduction in CD163 surface 459 
expression in PAMs (Costa-Hurtado et al., 2013). In our study, the decrease of CD163+ 460 
macrophages, an important cell subset to tackle bacterial infections (Fabriek et al., 2009), 461 
points out to a mechanism involved in the impairment of the local pulmonary immune 462 
response. This fact may potentially favour the co-infection with secondary commensal 463 
microorganisms leading to bronchopneumonia.  464 
 465 
CD14 and iNOS are involved in lung inflammation after infection with PRRSV (Chen et 466 
al., 2014; Lee and Kleiboeker, 2005; Van Gucht et al., 2004, 2005; Yan et al., 2017)  467 
Upregulation of CD14, as lipopolysaccharides (LPS) co-receptor, after infection with 468 
PRRSV sensitises the lungs for the production of proinflammatory cytokines and 469 
respiratory signs upon exposure to bacterial LPS (Van Gucht et al., 2005). For its part, 470 
iNOS is mainly expressed in response to different stimuli, such as cytokines and LPS, 471 
playing a role in tissue injury upon production of NO (Chen et al., 2014; Cho and Chae, 472 
2002; Vlahos et al., 2011; Yan et al., 2017). In this study, an increase in the number of 473 
CD14+ cells after PRRSV-1 infection was observed in association with suppurative 474 
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bronchopneumonia, which was more evident in Lena-infected piglets at 6 – 8 dpi. This 475 
increase was mainly due to CD14+ monocytes, interstitial and intravascular macrophages 476 
infiltrating extensive areas of the interstitium. The influx of CD14+ monocytes and 477 
immature macrophages may be explained by an attempt to replenish the loss of CD163+ 478 
macrophages contributing to clearance of cellular debris and resolution of inflammation, 479 
restoring the normal lung function. On the other hand, the increase of CD14+ cells implies 480 
a higher availability of the LPS-LBP complex receptor, which is likely to sensitise the 481 
lung to future secondary bacterial infections making the onset of PRDC easier (Van Gucht 482 
et al., 2005). In the case of iNOS, a significant increase in the number of iNOS+ cells was 483 
observed in areas of interstitial pneumonia as well as bronchopneumonia in Lena-infected 484 
pigs. The induction of iNOS has been associated with both a direct effect of the viral 485 
replication or viral components and an indirect effect mediated by cytokines, such as IFN-486 
γ, or by LPS (Akaike and Maeda, 2000; Chen et al., 2014; Lee and Kleiboeker, 2005). Of 487 
note, the peak of iNOS in Lena-infected animals appeared in our study just after the peak 488 
of PRRSV replication in the lung as well as after the peak of serum IFN-γ, being 489 
associated with the maximum lung injury and bronchopneumonia lesion. These factors 490 
may play a role in the regulation of iNOS expression along PRRSV infection and its role 491 
in lung injury development (Chen et al., 2014; Lee and Kleiboeker, 2005; Yan et al., 492 
2017). 493 
 494 
After a cascade of proinflammatory events, the host is able to trigger off the release of 495 
anti-inflammatory or regulatory mediators to restrain the extent of the injury. Thus, the 496 
role of CD200R1 and FoxP3 was evaluated in the present study. A strong positive 497 
correlation was detected among the frequency of CD200R1+ cells and the microscopic 498 
score which was mainly associated with a higher severity of typical interstitial pneumonia 499 
21 
 
and suppurative bronchopneumonia in Lena-infected pigs. Likewise, an increase in the 500 
frequency of FoxP3+ cells between 6 and 8 dpi was triggered by both PRRSV-1 strains 501 
when the lung injury was higher. CD200R1 has been involved in reducing the expression 502 
of pro-inflammatory cytokines in a wide range of inflammatory diseases (Vaine and 503 
Soberman, 2014), nevertheless to the best of the authors’ knowledge, the role of 504 
CD200R1 in viral diseases of swine is largely unknown.  Previous studies in a murine 505 
model reported that influenza virus infection induced the upregulation of CD200R1 in 506 
macrophages, decreasing their responsiveness and increasing the sensitivity to bacterial 507 
infection and finally severe lung injury (Snelgrove et al., 2008; Vaine and Soberman, 508 
2014). In contrast, CD200/CD200R1 signalling pathway limited type I IFN production 509 
during coronavirus infection protecting the host from cytokine storm (Vaine and 510 
Soberman, 2014). In addition, FoxP3 has been reported as a potential inhibitor of the cell-511 
mediated immune response in pigs upon PRRSV infection (Ferrarini et al., 2015; Silva-512 
Campa et al., 2009; 2010); but also induction of Tregs has been described in the lungs 513 
and tracheobronchial lymph nodes in PRRSV-infected pigs (Nedumpun et al., 2018).  514 
However, its role in the immunopathogenesis of PRRSV-induced lung injury is 515 
unexplored. PD1/PDL1 modulation and FoxP3+ cells have been pointed out to play a dual 516 
role upon viral infections, restricting immune inflammation-induced tissue damage and 517 
encouraging lung repair during acute phase of infection (Lin et al., 2018; Singh et al., 518 
2019), but leading to exhaustion and suppression of antiviral immune responses in the 519 
chronic infection (Arpaia et al., 2015; Schönrich and Raftery, 2019; Wang et al., 2018). 520 
Taken together, our results highlight the upregulation of CD200R1 and FoxP3 as 521 
mechanisms involved in the constraint and recovery of lung injury during acute PRRSV 522 
infection. Further studies are needed to determine the mechanisms involved in the 523 
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activation of these molecules during acute PRRSV as well as their role and related 524 
signalling pathways along the persistent infection. 525 
 526 
5. Conclusion 527 
The present study dissects the immunopathology of lung injury along an acute infection 528 
with PRRSV-1 strains of different virulence, revealing a drop in the number of CD163+ 529 
cells together with an enhancement in the expression of CD14 and iNOS as mechanisms 530 
involved in the earlier and higher extent of lung lesion in Lena-infected piglets. These 531 
changes could sensitise the lung to future secondary bacterial infections. In addition, the 532 
increase in the number of CD14+ cells is likely to respond to an attempt to replenish the 533 
CD163+ macrophages subset lost along the infection with both PRRSV-1 strains. On the 534 
other hand, the increase in the expression of CD200R1 and FoxP3 represents potential 535 
pathways activated to contain the inflammatory response.   536 
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Figure Legends 878 
Fig. 1. Clinical signs score, macroscopic and microscopic lung outcomes. Clinical 879 
signs and temperature were recorded from 1 day prior to infection until 8 dpi to evaluate 880 
clinical signs and hyperthermia (> 40.5°C). Plots show the mean average of clinical signs 881 
score (A) and rectal temperature (B) for control group (gray circles), 3249-infected group 882 
(green triangle) and Lena-infected group (red diamonds). “a” indicates a significant 883 
difference between the Lena and 3249 and control groups, “b” a significant difference 884 
between the Lena and 3249 groups and “c” a significant difference between the 3249 and 885 
control groups. P value lower than 0.05 was considered statistically significant and 886 
represented as * P ≤ 0.05, ** P ≤ 0.01 and *** P ≤ 0.001. Days post-inoculation, dpi. (C) 887 
At necropsy, lungs were scored and processed for histological and immunohistochemical 888 
studies. Box plots display the macroscopic lung score for each group (control, gray 889 
circles; 3249, green triangles; Lena, red diamonds) for each time point. P value lower 890 
than 0.05 was considered statistically significant and represented as * P ≤ 0.05, ** P ≤ 891 
0.01 and *** P ≤ 0.001. Days post-inoculation, dpi. (D) Lung appearance of piglets from 892 
the control, 3249 and Lena group at 8 dpi are shown in the pictures. (E) Box plots show 893 
the microscopic lung score for each group (control, gray circles; 3249, green triangles; 894 
Lena, red diamonds) for each time point. Each symbol represents individual data for each 895 
pig. P value lower than 0.05 was considered statistically significant and represented as * 896 
P ≤ 0.05, ** P ≤ 0.01 and *** P ≤ 0.001. Days post-inoculation, dpi. (F) 897 
Photomicrographs of the medial lung lobe illustrate characteristic interstitial pneumonia 898 
in a representative 3249-infected pig (left) and suppurative bronchopneumonia in a 899 




Fig. 2. PRRSV viraemia, lung viral load, IFN-γ and IL-6 level in sera. PRRSV viral 902 
load was quantified in sera (A) and lung (B) by RT-qPCR. The concentration of IFN-γ 903 
(C) and IL-6 (D) were assessed in sera by using ELISA. Diagrams (A) and (B) display 904 
the viral load (eq TCID50/mL) and (C) and (D) the concentration of the cytokines IFN-γ 905 
(pg/mL) and IL-6 (pg/mL), respectively, for each group (control, gray circles; 3249, green 906 
triangles; Lena, red diamonds) and time point. All data are reported as the mean with 907 
range of results obtained for each group and time point. P value lower than 0.05 was 908 
considered statistically significant and represented as * P ≤ 0.05 and ** P ≤ 0.01. “a” 909 
indicates a significant difference between the Lena and 3249 and control groups and “b” 910 
a significant difference between the 3249 and control groups. Days post-inoculation, dpi. 911 
 912 
Fig. 3.  Immunohistochemical expression of PRRSV-N-protein and CD163 in lung 913 
tissue. Lung tissue sections were immunolabelled for both antigens. Photomicrographs 914 
of the medial lung lobe illustrate the expression of PRRSV-N-protein in a 3249-infected 915 
(A) and Lena-infected (B) pig, which was mainly observed in PAMs (3A-3B, insets). 916 
IHC. Bar, 100 μm. Photomicrographs of the medial lung lobe illustrate the expression of 917 
CD163 in a representative control (C) and Lena-infected (D) pig. Immunolabelling of 918 
CD163 scavenger receptor was mainly observed in the cytoplasm and cell surface of 919 
PAMs found in the pulmonary alveolus and in a lesser extent in interstitial and 920 
intravascular macrophages (3C-3D, insets). IHC. Bar, 50 μm. (E) The diagram displays 921 
the number of PRRSV-N-protein+ (primary axis) and CD163+ (secondary axis) cells/mm2. 922 
Scatter dot plot shows the number of CD163+ macrophages (secondary axis) for each 923 
animal (control, gray circles; 3249, green triangles; Lena, red diamonds) and coloured 924 
lines the average for each group and time point. Control baseline displays the mean of the 925 
number of positive cells along the study in control group. P value lower than 0.05 was 926 
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considered statistically significant and represented as * P ≤ 0.05 and ** P ≤ 0.01. The 927 
grey bars display the average of total number of PRRSV-N-protein+ macrophages 928 
(primary axis) for each group and time point. “a” indicates a significant difference 929 
between the Lena and 3249 groups. Days post-inoculation, dpi. 930 
 931 
Fig. 4.  Immunohistochemical expression of CD14 and iNOS in lung tissue. Lung 932 
tissue sections were immunolabelled for both antigens. Photomicrographs of the medial 933 
lung lobe illustrate the expression of CD14 in a 3249-infected (A) and Lena-infected pig 934 
(B), which was mainly expressed on the cell membrane and cytoplasm of monocytes, 935 
interstitial and intravascular macrophages (4A-4B, insets). IHC. Bar, 100 μm. 936 
Photomicrographs of the medial lung lobe illustrate the expression of iNOS in a 937 
representative control (C) and Lena-infected (D) pig. iNOS was observed primarily in the 938 
cytoplasm of PAMs and interstitial macrophages detected in foci of interstitial pneumonia 939 
and bronchopneumonia (4C-4D, insets). IHC. Bar, 100 μm. (E) Box plots shows the 940 
number of CD14+ cells/mm2 for each group (control, gray circles; 3249, green triangles; 941 
Lena, red diamonds) and time point. (F) Box plots display the number of iNOS+ cells for 942 
each group (Control, gray circles; 3249, green triangles; Lena, red diamonds) and time 943 
point. Control baseline displays the mean of the number of positive cells along the study 944 
in control group. P value lower than 0.05 was considered statistically significant and 945 
represented as * P ≤ 0.05 and ** P ≤ 0.01. Days post-inoculation, dpi. 946 
 947 
Fig. 5.  Immunohistochemical expression of CD200R1 and FoxP3 in lung tissue. 948 
Lung tissue sections were immunolabelled for both antigens. Photomicrographs of the 949 
medial lung lobe illustrate the expression of CD200R1 in a 3249-infected (A) and Lena-950 
infected (B) pig, which was mainly detected in the cytoplasm of intravascular and 951 
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interstitial macrophages located inside or surrounding bronchopneumonia foci (5A-5B, 952 
insets). IHC. Bar, 50 μm. Photomicrographs of the medial lung lobe illustrate the 953 
expression of FoxP3 in a representative control (C) and Lena-infected (D) pig. FoxP3 954 
yielded a nuclear immunolabelling in lymphocytes mainly located in areas of atelectasis 955 
and interstitial pneumonia (5C-5D, insets). IHC. Bar, 100 μm. (E) The diagram displays 956 
the number of CD200R1+ cells/mm2 versus the microscopic lung score. Scatter dot plot 957 
shows the number of CD200R1+ cells (primary axis) for each animal (control, gray 958 
circles; 3249, green triangles; Lena, red diamonds) and coloured lines the average for 959 
each group and day point. The gray bar displays the microscopic lung score (secondary 960 
axis) for each group (control, gray circles; 3249, green triangles; Lena, red diamonds) at 961 
each time point. (F) Box plots shows the number of FoxP3+ cells for each group (control, 962 
gray circles; 3249, green triangles; Lena, red diamonds) and time point. Control baseline 963 
displays the mean of the number of positive cells along the study in control group. P value 964 
lower than 0.05 was considered statistically significant and represented as * P ≤ 0.05 and 965 




• Lena virulent strain caused an increase in sera levels of IFN-γ and IL-6.  
• Lung viral load and PRRSV-N-protein+ cells were inversely correlated with 
CD163+ macrophages in the lung. 
• CD14+ cells infiltrated interstitium to possibly replenish macrophages subsets. 
• Lena-induced microscopic lung injury was linked to an increase of iNOS+ cells. 












Clone Source Blocking solution Dilution Antigen retrieval 
PRRSV-N- protein  mAb SDOW17 
Rural Technologies, 
Brookings, SD, USA 
BSA 2% 1:500 
Protease XIV 
CD163 mAb 2A10/11 In house, INIA NGS 10% neat Citrate pH 6 
CD200R1 mAb PCT3 In house, INIA BSA 2% neat Protease XIV 
CD14 mAb MIL2 Biorad, Hercules, CA BSA 2% 1:100 Protease XIV 
iNOS pAb NA 
Neomarers, Fremont, 
CA, USA 
BSA 2% 1:750 
Citrate pH 6* 
FoxP3 mAb FJK-16s 
eBioscience™, Bacelona, 
Spain 
NGS 10%** 1:100 Citrate pH 6* 
PRRSV, Porcine reproductive and respiratory syndrome virus; CD200R1, CD200 Receptor 1; iNOS, inducible nitric oxide synthase; FoxP3, 2 
forkhead box protein 3; mAb, monoclonal antibody; pAb, polyclonal antibody; BSA, Bovine Serum Albumin; NGS, Normal Goat Serum; NA, 3 
not applicable; Citrate pH 6, microwave heat treatment at 420W for 10 minutes; Protease XIV, enzymatic digestion with protease type XIV 4 
(Sigma-Aldrich) at 38º C for 8 minutes; Citrate pH 6*, autoclave treatment at 121º C for 10 min; NGS 10%**: NGS diluted in  phosphate buffer 5 
saline with 10% tween 20.  6 
Table 2. Statistical correlations found in piglets infected with virulent Lena strain throughout the study. For all data, a P value lower than 0.05 7 















CD163 CD200R1 FoxP3 CD14 iNOS 
Temperature - 0.92**** 0.79**** 0.76**** 0.67* NS 0.62** 0.64** 0.78**** NS NS NS NS NS 
Clinical signs 
score 
 - 0.84**** 
0.72**** 0.72*** NS 0.68** 0.75**** 0.78**** NS -0.63** NS NS NS 
Viraemia   - 0.77**** 0.71** NS NS 0.62** 0.74** -0.78*** NS NS NS NS 
Lung viral load    - 0.71*** NS 0.72*** 0.68** 0.85**** -0.71*** 0.63** NS NS NS 
IFN-γ     - NS NS 0.62* 0.62* NS 0.61** 0.70** NS NS 
IL-6      - NS NS 0.55* NS 0.56* NS 0.84*** NS 
Gross lesion       - 0.8*** NS NS 0.73*** NS NS NS 
Microscopic lesion        - 0.68** NS 0.91**** NS NS NS 
PRRSV-N-protein         - -0.62** 0.63** NS NS NS 
CD163          - NS NS NS NS 
CD200R1           - NS 0.55* NS 
FoxP3            - NS NS 
CD14             - 0.52* 
iNOS              - 
NS: not statistically significant or with r < 0.6. Correlation coefficients were considered relevant with r > 0.6 and P < 0.05. 9 
